IL-2 Induces Transient Arrest in the G1 Phase to Protect Cervical Cancer Cells from Entering Apoptosis

Interleukin 2 (IL-2) has been used for the treatment of different types of cancer that express the IL-2 receptor (IL-2R). However, the effect of IL-2 on cervical cancer cells is unknown. IL-2R is present in normal cells of the immune system but not in the healthy cervix. We report that IL-2R is expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lagunas-Cruz, María del Carmen, Valle-Mendiola, Arturo, Trejo-Huerta, Jonathan, Rocha-Zavaleta, Leticia, Mora-García, María de Lourdes, Gutiérrez-Hoya, Adriana, Weiss-Steider, Benny, Soto-Cruz, Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791272/
https://www.ncbi.nlm.nih.gov/pubmed/31662754
http://dx.doi.org/10.1155/2019/7475295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791272/
https://www.ncbi.nlm.nih.gov/pubmed/31662754
http://dx.doi.org/10.1155/2019/7475295

Ejemplares similares